
|Videos|February 3, 2016
The Challenge of High Cost Drugs in Specialty Pharmacy
Author(s)Davy James, Managing Editor
Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape.
Advertisement
Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
High Costs and Coverage Gaps Remain Key Barriers to NCCN-Preferred CLL Therapies
2
MONALEESA Data Reveal Robust Long-Term Disease Control With Ribociclib
3
Avapritinib Delivers Durability, Disease-Modification in Advanced Systemic Mastocytosis
4
A Cup of Coffee or Life-Saving Drugs: Shifting Decision-Making Practices in Health Care
5




















































































































































































































